AAAAAA

   
Results: 1-9 |
Results: 9
Efficacy of paroxetine in the treatment of adolescent major depression: A randomized, controlled trial
Authors: Keller, MB Ryan, ND Strober, M Klein, RG Kutcher, SP Birmaher, B Hagino, OR Koplewicz, H Carlson, GA Clarke, GN Emslie, GJ Feinberg, D Geller, B Kusumakar, V Papatheodorou, G Sack, WH Sweeney, M Wagner, DK Weller, EB Winters, NC Oakes, R McCafferty, JP
Citation: Mb. Keller et al., Efficacy of paroxetine in the treatment of adolescent major depression: A randomized, controlled trial, J AM A CHIL, 40(7), 2001, pp. 762-772
Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression
Authors: Nemeroff, CB Evans, DL Gyulai, L Sachs, GS Bowden, CL Gergel, IP Oakes, R Pitts, CD
Citation: Cb. Nemeroff et al., Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression, AM J PSYCHI, 158(6), 2001, pp. 906-912
Low dose fractionated radiation enhances the radiosensitization effect of paclitaxel in colorectal tumor cells with mutant p53
Authors: Chendil, D Oakes, R Alcock, RA Patel, N Mayhew, C Mohiuddin, M Gallicchio, VS Ahmed, MM
Citation: D. Chendil et al., Low dose fractionated radiation enhances the radiosensitization effect of paclitaxel in colorectal tumor cells with mutant p53, CANCER, 89(9), 2000, pp. 1893-1900
Developing a business-IT coevolutionary change plan
Authors: Bustard, D Greer, D He, ZL Lundy, P Wilkie, G Oakes, R
Citation: D. Bustard et al., Developing a business-IT coevolutionary change plan, SYSTEMS MODELING FOR BUSINESS PROCESS IMPROVEMENT, 2000, pp. 213-232
RIPPLE: Retaining integrity in process products over their long-term evolution
Authors: Bustard, DW Greer, D He, Z Lundy, PJ Wilkie, FG Oakes, R
Citation: Dw. Bustard et al., RIPPLE: Retaining integrity in process products over their long-term evolution, SYSTEMS ENGINEERING FOR BUSINESS PROCESS CHANGE, 2000, pp. 51-65
Treating men with predominantly nonpsychogenic erectile dysfunction with intracavernosal vasoactive intestinal polypeptide and phentolamine mesylate in a novel auto-injector system: a multicentre double-blind placebo-controlled study
Authors: Dinsmore, WW Gingell, C Hackett, G Kell, P Savage, D Oakes, R Frentz, GD
Citation: Ww. Dinsmore et al., Treating men with predominantly nonpsychogenic erectile dysfunction with intracavernosal vasoactive intestinal polypeptide and phentolamine mesylate in a novel auto-injector system: a multicentre double-blind placebo-controlled study, BJU INT, 83(3), 1999, pp. 274-279
A double blind, placebo controlled study of intracavernosal vasoactive intestinal polypeptide and phenotolamine mesylate in a novel auto-injector forthe treatment of non-psychogenic erectile dysfunction
Authors: Sandhu, D Curless, E Dean, J Hackett, G Liu, S Savage, D Oakes, R Frentz, G
Citation: D. Sandhu et al., A double blind, placebo controlled study of intracavernosal vasoactive intestinal polypeptide and phenotolamine mesylate in a novel auto-injector forthe treatment of non-psychogenic erectile dysfunction, INT J IMPOT, 11(2), 1999, pp. 91-97
A double-blind placebo-controlled trial of paroxetine in the management ofsocial phobia (social anxiety disorder) in South Africa
Authors: Stein, DJ Berk, M Els, C Emsley, RA Gittelson, L Wilson, D Oakes, R Hunter, B
Citation: Dj. Stein et al., A double-blind placebo-controlled trial of paroxetine in the management ofsocial phobia (social anxiety disorder) in South Africa, S AFR MED J, 89(4), 1999, pp. 402-406
Opera, the state, and subsidy
Authors: Oakes, R
Citation: R. Oakes, Opera, the state, and subsidy, DISSENT, 46(4), 1999, pp. 126-126
Risultati: 1-9 |